Effectiveness of social prescribing for chronic disease prevention in adults: a systematic review and meta-analysis of randomised controlled trials

Author:

Htun Htet LinORCID,Teshale Achamyeleh BirhanuORCID,Cumpston Miranda SORCID,Demos Lisa,Ryan JoanneORCID,Owen AliceORCID,Freak-Poli RosanneORCID

Abstract

BackgroundSocial prescribing (SP) enables healthcare professionals to link patients with non-medical interventions available in the community to address underlying socioeconomic and behavioural determinants. We synthesised the evidence to understand the effectiveness of SP for chronic disease prevention.MethodsA systematic literature search was conducted using five databases and two registries. Eligible studies included randomised controlled trials of SP among community-dwelling adults recruited from primary care or community setting, investigating any chronic disease risk factors defined by the WHO (behavioural factors: smoking, physical inactivity, unhealthy diet and excessive alcohol consumption; metabolic factors: raised blood pressure, overweight/obesity, hyperlipidaemia and hyperglycaemia). Random effect meta-analyses were performed at two time points: completion of intervention and follow-up after trial.ResultsWe identified nine reports from eight trials totalling 4621 participants. All studies evaluated SP exercise interventions which were highly heterogeneous regarding the content, duration, frequency and length of follow-up. Majority of studies had some concerns for risk of bias. Meta-analysis revealed that SP likely increased physical activity (completion: mean difference (MD) 21 min/week, 95% CI 3 to 39, I2=0%; follow-up ≤12 months: MD 19 min/week, 95% CI 8 to 29, I2=0%). However, SP may not improve markers of adiposity, blood pressure, glucose and serum lipid. There were no eligible studies that primarily target unhealthy diet, smoking and excessive alcohol drinking behaviours.ConclusionsSP exercise interventions probably increased physical activity slightly; however, no benefits were observed for metabolic factors. Determining whether SP is effective in modifying the determinants of chronic diseases and promotes sustainable healthy behaviours is limited by the current evidence of quantification and uncertainty, warranting further rigorous studies.PROSPERO registration numberCRD42022346687.

Funder

Monash University

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference88 articles.

1. World Health Organization. Noncommunicable diseases. 2022. Available: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases [Accessed 26 Sep 2022].

2. The Social Determinants of Chronic Disease

3. Pantell MS , Prather AA , Downing JM , et al . Association of social and behavioral risk factors with earlier onset of adult hypertension and diabetes. JAMA Netw Open 2019;2:e193933. doi:10.1001/jamanetworkopen.2019.3933

4. The royal australian college of general practioners [Social prescribing report and recommendations]. 2019. Available: https://www.racgp.org.au/advocacy/advocacy-resources/social-prescribing-report-and-recommendations [Accessed 10 Oct 2022].

5. The clinical application of the biopsychosocial model;Engel;J Med Philos,1981

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3